With limited lab capacity and the need to accelerate several of our candidates, we were looking for a fast and reliable screening solution, and Nagi Bioscience delivered exactly that. Their collaborative approach and clear communication made it easy to move the project forward; from design to execution, we felt supported and actively involved throughout. Their services revealed new insights and opened up exciting possibilities for exploring the potential of our strains in health applications related to healthy aging, helping us advance our research further.

Karl Alex Hedin, PhD

Post-Doctoral Researcher

We are very pleased with the experience of the Nagi Bioscience team and the exceptional quality of their work. Their innovative technology has been instrumental in allowing us to gather critical scientific data quickly, providing invaluable insights that significantly advance our research in longevity.

Erez Aminov

CEO

Spending two days at Nagi Bioscience was a great experience. The level of innovation and automation in their Discovery Pack experiment exceeded my expectations. The team was knowledgeable and committed to ensuring a smooth and productive experience.

Sara Irish

RC-funded PhD candidate at Alexei Maklakov’s Research Lab

We had a highly positive experience with Nagi Bioscience’s services. Their innovative assays provided a reliable alternative to mouse studies by leveraging the relatively short lifespan of C. elegans worms (2-3 weeks) and the high conservation of our target from worms to human. Nagi’s approach delivered results faster and at lower cost.

Senior Manager, Translational Pharmacology

By improving precision and enhancing reproducibility, SydLab™ One empower us to explore new frontiers in critical fields of medical science. We are excited to leverage this fully automated, end-to-end solution in our projects and accelerate the pace of scientific discovery.

Prof. Konstantinos Palikaras, PhD

Group Leader of the Unit of Neurogenetics and Ageing, Laboratory of Physiology

Working with Nagi Bioscience enabled us to rapidly generate meaningful in vivo data using their C. elegans platform. Their high-throughput approach provided clear, quantifiable insights into the lifespan and functional effects of our lead combinations— critical data that helped de-risk and prioritize our therapeutic strategy. The team’s scientific expertise, flexibility, and collaborative mindset made them an ideal partner during this pivotal phase of our preclinical development.

Irina Fingerhut

Co-Founder/Sole Director

We have a fantastic opportunity to use this technology to generate high-throughput data, while maintaining a high resolution by analysing C. elegans worms individually to uncover new insights that will drive advancements in the neurobiology of ageing.

Prof. Ellen Nollen, PhD

Group Leader of the Laboratory of Molecular Neurobiology of Ageing

We are thrilled to be part of Nagi’s Priority Access Program. Using SydLab™ One, we are enhancing natural product research by replacing manual C. elegans assays while delivering more detailed and reproducible results.

Prof. Timo H. J. Niedermeyer, PhD

Group Leader of the Pharmaceutical Biology Group